img

Global Rabies Immune Globulin Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Rabies Immune Globulin Market Insights, Forecast to 2034

Rabies immunoglobulin (RIG) is a medication made up of antibodies against the rabies virus. It is used to prevent rabies following exposure.
Global Rabies Immune Globulin market is expected to reach to US$ 455 million in 2024, with a positive growth of %, compared with US$ 424 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Rabies Immune Globulin industry is evaluated to reach US$ 694.4 million in 2029. The CAGR will be 7.3% during 2024 to 2029.
The Rabies Immune Globulin market is driven by the critical need to prevent and treat rabies infections effectively. Rabies immune globulin (RIG) is a key component of post-exposure prophylaxis, providing passive immunity against the virus. The increased awareness of rabies' potential severity, particularly in regions with higher prevalence rates, propels market growth. Additionally, the rising number of travelers and potential exposure to rabies in endemic areas contribute to demand. However, challenges include the limited availability of RIG in certain regions and the high cost associated with its production and administration. Ensuring timely access to RIG, especially in remote or resource-constrained areas, and addressing potential allergic reactions or adverse events are ongoing concerns. The market's success depends on the collaboration between healthcare systems and regulatory bodies to ensure sufficient availability, proper distribution, and affordability of rabies immune globulin, ultimately reducing the global burden of this deadly disease.
Report Covers
This report presents an overview of global Rabies Immune Globulin market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Rabies Immune Globulin market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


CSL Behring
Grifols
Sanofi
Sichuan Yuanda Shuyang
CNBG
Kamada
CBPO
Shuanglin Bio
Weiguang Bio
Shanghai RAAS
Bharat Serum
VINS
Segment by Type
ERIG
HRIG

Segment by Application


Category II Exposure
Category III Exposure

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Rabies Immune Globulin plant distribution, commercial date of Rabies Immune Globulin, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Rabies Immune Globulin introduction, etc. Rabies Immune Globulin Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Rabies Immune Globulin
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Rabies Immune Globulin Product Introduction
1.2 Market by Type
1.2.1 Global Rabies Immune Globulin Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 ERIG
1.2.3 HRIG
1.3 Market by Application
1.3.1 Global Rabies Immune Globulin Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Category II Exposure
1.3.3 Category III Exposure
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Rabies Immune Globulin Sales Estimates and Forecasts 2018-2029
2.2 Global Rabies Immune Globulin Revenue by Region
2.2.1 Global Rabies Immune Globulin Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Rabies Immune Globulin Revenue by Region (2018-2024)
2.2.3 Global Rabies Immune Globulin Revenue by Region (2024-2029)
2.2.4 Global Rabies Immune Globulin Revenue Market Share by Region (2018-2029)
2.3 Global Rabies Immune Globulin Sales Estimates and Forecasts 2018-2029
2.4 Global Rabies Immune Globulin Sales by Region
2.4.1 Global Rabies Immune Globulin Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Rabies Immune Globulin Sales by Region (2018-2024)
2.4.3 Global Rabies Immune Globulin Sales by Region (2024-2029)
2.4.4 Global Rabies Immune Globulin Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Rabies Immune Globulin Sales by Manufacturers
3.1.1 Global Rabies Immune Globulin Sales by Manufacturers (2018-2024)
3.1.2 Global Rabies Immune Globulin Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Rabies Immune Globulin in 2022
3.2 Global Rabies Immune Globulin Revenue by Manufacturers
3.2.1 Global Rabies Immune Globulin Revenue by Manufacturers (2018-2024)
3.2.2 Global Rabies Immune Globulin Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Rabies Immune Globulin Revenue in 2022
3.3 Global Key Players of Rabies Immune Globulin, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Rabies Immune Globulin Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Rabies Immune Globulin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Rabies Immune Globulin, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Rabies Immune Globulin, Product Offered and Application
3.8 Global Key Manufacturers of Rabies Immune Globulin, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Rabies Immune Globulin Sales by Type
4.1.1 Global Rabies Immune Globulin Historical Sales by Type (2018-2024)
4.1.2 Global Rabies Immune Globulin Forecasted Sales by Type (2024-2029)
4.1.3 Global Rabies Immune Globulin Sales Market Share by Type (2018-2029)
4.2 Global Rabies Immune Globulin Revenue by Type
4.2.1 Global Rabies Immune Globulin Historical Revenue by Type (2018-2024)
4.2.2 Global Rabies Immune Globulin Forecasted Revenue by Type (2024-2029)
4.2.3 Global Rabies Immune Globulin Revenue Market Share by Type (2018-2029)
4.3 Global Rabies Immune Globulin Price by Type
4.3.1 Global Rabies Immune Globulin Price by Type (2018-2024)
4.3.2 Global Rabies Immune Globulin Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Rabies Immune Globulin Sales by Application
5.1.1 Global Rabies Immune Globulin Historical Sales by Application (2018-2024)
5.1.2 Global Rabies Immune Globulin Forecasted Sales by Application (2024-2029)
5.1.3 Global Rabies Immune Globulin Sales Market Share by Application (2018-2029)
5.2 Global Rabies Immune Globulin Revenue by Application
5.2.1 Global Rabies Immune Globulin Historical Revenue by Application (2018-2024)
5.2.2 Global Rabies Immune Globulin Forecasted Revenue by Application (2024-2029)
5.2.3 Global Rabies Immune Globulin Revenue Market Share by Application (2018-2029)
5.3 Global Rabies Immune Globulin Price by Application
5.3.1 Global Rabies Immune Globulin Price by Application (2018-2024)
5.3.2 Global Rabies Immune Globulin Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Rabies Immune Globulin Market Size by Type
6.1.1 US & Canada Rabies Immune Globulin Sales by Type (2018-2029)
6.1.2 US & Canada Rabies Immune Globulin Revenue by Type (2018-2029)
6.2 US & Canada Rabies Immune Globulin Market Size by Application
6.2.1 US & Canada Rabies Immune Globulin Sales by Application (2018-2029)
6.2.2 US & Canada Rabies Immune Globulin Revenue by Application (2018-2029)
6.3 US & Canada Rabies Immune Globulin Market Size by Country
6.3.1 US & Canada Rabies Immune Globulin Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Rabies Immune Globulin Sales by Country (2018-2029)
6.3.3 US & Canada Rabies Immune Globulin Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Rabies Immune Globulin Market Size by Type
7.1.1 Europe Rabies Immune Globulin Sales by Type (2018-2029)
7.1.2 Europe Rabies Immune Globulin Revenue by Type (2018-2029)
7.2 Europe Rabies Immune Globulin Market Size by Application
7.2.1 Europe Rabies Immune Globulin Sales by Application (2018-2029)
7.2.2 Europe Rabies Immune Globulin Revenue by Application (2018-2029)
7.3 Europe Rabies Immune Globulin Market Size by Country
7.3.1 Europe Rabies Immune Globulin Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Rabies Immune Globulin Sales by Country (2018-2029)
7.3.3 Europe Rabies Immune Globulin Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Rabies Immune Globulin Market Size
8.1.1 China Rabies Immune Globulin Sales (2018-2029)
8.1.2 China Rabies Immune Globulin Revenue (2018-2029)
8.2 China Rabies Immune Globulin Market Size by Application
8.2.1 China Rabies Immune Globulin Sales by Application (2018-2029)
8.2.2 China Rabies Immune Globulin Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Rabies Immune Globulin Market Size by Type
9.1.1 Asia Rabies Immune Globulin Sales by Type (2018-2029)
9.1.2 Asia Rabies Immune Globulin Revenue by Type (2018-2029)
9.2 Asia Rabies Immune Globulin Market Size by Application
9.2.1 Asia Rabies Immune Globulin Sales by Application (2018-2029)
9.2.2 Asia Rabies Immune Globulin Revenue by Application (2018-2029)
9.3 Asia Rabies Immune Globulin Sales by Region
9.3.1 Asia Rabies Immune Globulin Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Rabies Immune Globulin Revenue by Region (2018-2029)
9.3.3 Asia Rabies Immune Globulin Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Rabies Immune Globulin Market Size by Type
10.1.1 Middle East, Africa and Latin America Rabies Immune Globulin Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Rabies Immune Globulin Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Rabies Immune Globulin Market Size by Application
10.2.1 Middle East, Africa and Latin America Rabies Immune Globulin Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Rabies Immune Globulin Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Rabies Immune Globulin Sales by Country
10.3.1 Middle East, Africa and Latin America Rabies Immune Globulin Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Rabies Immune Globulin Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Rabies Immune Globulin Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 CSL Behring
11.1.1 CSL Behring Company Information
11.1.2 CSL Behring Overview
11.1.3 CSL Behring Rabies Immune Globulin Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 CSL Behring Rabies Immune Globulin Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 CSL Behring Recent Developments
11.2 Grifols
11.2.1 Grifols Company Information
11.2.2 Grifols Overview
11.2.3 Grifols Rabies Immune Globulin Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Grifols Rabies Immune Globulin Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Grifols Recent Developments
11.3 Sanofi
11.3.1 Sanofi Company Information
11.3.2 Sanofi Overview
11.3.3 Sanofi Rabies Immune Globulin Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Sanofi Rabies Immune Globulin Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Sanofi Recent Developments
11.4 Sichuan Yuanda Shuyang
11.4.1 Sichuan Yuanda Shuyang Company Information
11.4.2 Sichuan Yuanda Shuyang Overview
11.4.3 Sichuan Yuanda Shuyang Rabies Immune Globulin Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Sichuan Yuanda Shuyang Rabies Immune Globulin Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Sichuan Yuanda Shuyang Recent Developments
11.5 CNBG
11.5.1 CNBG Company Information
11.5.2 CNBG Overview
11.5.3 CNBG Rabies Immune Globulin Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 CNBG Rabies Immune Globulin Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 CNBG Recent Developments
11.6 Kamada
11.6.1 Kamada Company Information
11.6.2 Kamada Overview
11.6.3 Kamada Rabies Immune Globulin Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Kamada Rabies Immune Globulin Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Kamada Recent Developments
11.7 CBPO
11.7.1 CBPO Company Information
11.7.2 CBPO Overview
11.7.3 CBPO Rabies Immune Globulin Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 CBPO Rabies Immune Globulin Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 CBPO Recent Developments
11.8 Shuanglin Bio
11.8.1 Shuanglin Bio Company Information
11.8.2 Shuanglin Bio Overview
11.8.3 Shuanglin Bio Rabies Immune Globulin Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 Shuanglin Bio Rabies Immune Globulin Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Shuanglin Bio Recent Developments
11.9 Weiguang Bio
11.9.1 Weiguang Bio Company Information
11.9.2 Weiguang Bio Overview
11.9.3 Weiguang Bio Rabies Immune Globulin Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 Weiguang Bio Rabies Immune Globulin Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Weiguang Bio Recent Developments
11.10 Shanghai RAAS
11.10.1 Shanghai RAAS Company Information
11.10.2 Shanghai RAAS Overview
11.10.3 Shanghai RAAS Rabies Immune Globulin Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 Shanghai RAAS Rabies Immune Globulin Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Shanghai RAAS Recent Developments
11.11 Bharat Serum
11.11.1 Bharat Serum Company Information
11.11.2 Bharat Serum Overview
11.11.3 Bharat Serum Rabies Immune Globulin Sales, Price, Revenue and Gross Margin (2018-2024)
11.11.4 Bharat Serum Rabies Immune Globulin Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Bharat Serum Recent Developments
11.12 VINS
11.12.1 VINS Company Information
11.12.2 VINS Overview
11.12.3 VINS Rabies Immune Globulin Sales, Price, Revenue and Gross Margin (2018-2024)
11.12.4 VINS Rabies Immune Globulin Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 VINS Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Rabies Immune Globulin Industry Chain Analysis
12.2 Rabies Immune Globulin Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Rabies Immune Globulin Production Mode & Process
12.4 Rabies Immune Globulin Sales and Marketing
12.4.1 Rabies Immune Globulin Sales Channels
12.4.2 Rabies Immune Globulin Distributors
12.5 Rabies Immune Globulin Customers
13 Market Dynamics
13.1 Rabies Immune Globulin Industry Trends
13.2 Rabies Immune Globulin Market Drivers
13.3 Rabies Immune Globulin Market Challenges
13.4 Rabies Immune Globulin Market Restraints
14 Key Findings in The Global Rabies Immune Globulin Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Rabies Immune Globulin Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of ERIG
Table 3. Major Manufacturers of HRIG
Table 4. Global Rabies Immune Globulin Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Rabies Immune Globulin Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Rabies Immune Globulin Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global Rabies Immune Globulin Revenue by Region (2024-2029) & (US$ Million)
Table 8. Global Rabies Immune Globulin Revenue Market Share by Region (2018-2024)
Table 9. Global Rabies Immune Globulin Revenue Market Share by Region (2024-2029)
Table 10. Global Rabies Immune Globulin Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 11. Global Rabies Immune Globulin Sales by Region (2018-2024) & (K Units)
Table 12. Global Rabies Immune Globulin Sales by Region (2024-2029) & (K Units)
Table 13. Global Rabies Immune Globulin Sales Market Share by Region (2018-2024)
Table 14. Global Rabies Immune Globulin Sales Market Share by Region (2024-2029)
Table 15. Global Rabies Immune Globulin Sales by Manufacturers (2018-2024) & (K Units)
Table 16. Global Rabies Immune Globulin Sales Share by Manufacturers (2018-2024)
Table 17. Global Rabies Immune Globulin Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global Rabies Immune Globulin Revenue Share by Manufacturers (2018-2024)
Table 19. Global Key Players of Rabies Immune Globulin, Industry Ranking, 2021 VS 2022 VS 2024
Table 20. Rabies Immune Globulin Price by Manufacturers 2018-2024 (US$/Unit)
Table 21. Global Rabies Immune Globulin Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Rabies Immune Globulin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rabies Immune Globulin as of 2022)
Table 23. Global Key Manufacturers of Rabies Immune Globulin, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Rabies Immune Globulin, Product Offered and Application
Table 25. Global Key Manufacturers of Rabies Immune Globulin, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Rabies Immune Globulin Sales by Type (2018-2024) & (K Units)
Table 28. Global Rabies Immune Globulin Sales by Type (2024-2029) & (K Units)
Table 29. Global Rabies Immune Globulin Sales Share by Type (2018-2024)
Table 30. Global Rabies Immune Globulin Sales Share by Type (2024-2029)
Table 31. Global Rabies Immune Globulin Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global Rabies Immune Globulin Revenue by Type (2024-2029) & (US$ Million)
Table 33. Global Rabies Immune Globulin Revenue Share by Type (2018-2024)
Table 34. Global Rabies Immune Globulin Revenue Share by Type (2024-2029)
Table 35. Rabies Immune Globulin Price by Type (2018-2024) & (US$/Unit)
Table 36. Global Rabies Immune Globulin Price Forecast by Type (2024-2029) & (US$/Unit)
Table 37. Global Rabies Immune Globulin Sales by Application (2018-2024) & (K Units)
Table 38. Global Rabies Immune Globulin Sales by Application (2024-2029) & (K Units)
Table 39. Global Rabies Immune Globulin Sales Share by Application (2018-2024)
Table 40. Global Rabies Immune Globulin Sales Share by Application (2024-2029)
Table 41. Global Rabies Immune Globulin Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global Rabies Immune Globulin Revenue by Application (2024-2029) & (US$ Million)
Table 43. Global Rabies Immune Globulin Revenue Share by Application (2018-2024)
Table 44. Global Rabies Immune Globulin Revenue Share by Application (2024-2029)
Table 45. Rabies Immune Globulin Price by Application (2018-2024) & (US$/Unit)
Table 46. Global Rabies Immune Globulin Price Forecast by Application (2024-2029) & (US$/Unit)
Table 47. US & Canada Rabies Immune Globulin Sales by Type (2018-2024) & (K Units)
Table 48. US & Canada Rabies Immune Globulin Sales by Type (2024-2029) & (K Units)
Table 49. US & Canada Rabies Immune Globulin Revenue by Type (2018-2024) & (US$ Million)
Table 50. US & Canada Rabies Immune Globulin Revenue by Type (2024-2029) & (US$ Million)
Table 51. US & Canada Rabies Immune Globulin Sales by Application (2018-2024) & (K Units)
Table 52. US & Canada Rabies Immune Globulin Sales by Application (2024-2029) & (K Units)
Table 53. US & Canada Rabies Immune Globulin Revenue by Application (2018-2024) & (US$ Million)
Table 54. US & Canada Rabies Immune Globulin Revenue by Application (2024-2029) & (US$ Million)
Table 55. US & Canada Rabies Immune Globulin Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 56. US & Canada Rabies Immune Globulin Revenue by Country (2018-2024) & (US$ Million)
Table 57. US & Canada Rabies Immune Globulin Revenue by Country (2024-2029) & (US$ Million)
Table 58. US & Canada Rabies Immune Globulin Sales by Country (2018-2024) & (K Units)
Table 59. US & Canada Rabies Immune Globulin Sales by Country (2024-2029) & (K Units)
Table 60. Europe Rabies Immune Globulin Sales by Type (2018-2024) & (K Units)
Table 61. Europe Rabies Immune Globulin Sales by Type (2024-2029) & (K Units)
Table 62. Europe Rabies Immune Globulin Revenue by Type (2018-2024) & (US$ Million)
Table 63. Europe Rabies Immune Globulin Revenue by Type (2024-2029) & (US$ Million)
Table 64. Europe Rabies Immune Globulin Sales by Application (2018-2024) & (K Units)
Table 65. Europe Rabies Immune Globulin Sales by Application (2024-2029) & (K Units)
Table 66. Europe Rabies Immune Globulin Revenue by Application (2018-2024) & (US$ Million)
Table 67. Europe Rabies Immune Globulin Revenue by Application (2024-2029) & (US$ Million)
Table 68. Europe Rabies Immune Globulin Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 69. Europe Rabies Immune Globulin Revenue by Country (2018-2024) & (US$ Million)
Table 70. Europe Rabies Immune Globulin Revenue by Country (2024-2029) & (US$ Million)
Table 71. Europe Rabies Immune Globulin Sales by Country (2018-2024) & (K Units)
Table 72. Europe Rabies Immune Globulin Sales by Country (2024-2029) & (K Units)
Table 73. China Rabies Immune Globulin Sales by Type (2018-2024) & (K Units)
Table 74. China Rabies Immune Globulin Sales by Type (2024-2029) & (K Units)
Table 75. China Rabies Immune Globulin Revenue by Type (2018-2024) & (US$ Million)
Table 76. China Rabies Immune Globulin Revenue by Type (2024-2029) & (US$ Million)
Table 77. China Rabies Immune Globulin Sales by Application (2018-2024) & (K Units)
Table 78. China Rabies Immune Globulin Sales by Application (2024-2029) & (K Units)
Table 79. China Rabies Immune Globulin Revenue by Application (2018-2024) & (US$ Million)
Table 80. China Rabies Immune Globulin Revenue by Application (2024-2029) & (US$ Million)
Table 81. Asia Rabies Immune Globulin Sales by Type (2018-2024) & (K Units)
Table 82. Asia Rabies Immune Globulin Sales by Type (2024-2029) & (K Units)
Table 83. Asia Rabies Immune Globulin Revenue by Type (2018-2024) & (US$ Million)
Table 84. Asia Rabies Immune Globulin Revenue by Type (2024-2029) & (US$ Million)
Table 85. Asia Rabies Immune Globulin Sales by Application (2018-2024) & (K Units)
Table 86. Asia Rabies Immune Globulin Sales by Application (2024-2029) & (K Units)
Table 87. Asia Rabies Immune Globulin Revenue by Application (2018-2024) & (US$ Million)
Table 88. Asia Rabies Immune Globulin Revenue by Application (2024-2029) & (US$ Million)
Table 89. Asia Rabies Immune Globulin Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 90. Asia Rabies Immune Globulin Revenue by Region (2018-2024) & (US$ Million)
Table 91. Asia Rabies Immune Globulin Revenue by Region (2024-2029) & (US$ Million)
Table 92. Asia Rabies Immune Globulin Sales by Region (2018-2024) & (K Units)
Table 93. Asia Rabies Immune Globulin Sales by Region (2024-2029) & (K Units)
Table 94. Middle East, Africa and Latin America Rabies Immune Globulin Sales by Type (2018-2024) & (K Units)
Table 95. Middle East, Africa and Latin America Rabies Immune Globulin Sales by Type (2024-2029) & (K Units)
Table 96. Middle East, Africa and Latin America Rabies Immune Globulin Revenue by Type (2018-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Rabies Immune Globulin Revenue by Type (2024-2029) & (US$ Million)
Table 98. Middle East, Africa and Latin America Rabies Immune Globulin Sales by Application (2018-2024) & (K Units)
Table 99. Middle East, Africa and Latin America Rabies Immune Globulin Sales by Application (2024-2029) & (K Units)
Table 100. Middle East, Africa and Latin America Rabies Immune Globulin Revenue by Application (2018-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Rabies Immune Globulin Revenue by Application (2024-2029) & (US$ Million)
Table 102. Middle East, Africa and Latin America Rabies Immune Globulin Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 103. Middle East, Africa and Latin America Rabies Immune Globulin Revenue by Country (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Rabies Immune Globulin Revenue by Country (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America Rabies Immune Globulin Sales by Country (2018-2024) & (K Units)
Table 106. Middle East, Africa and Latin America Rabies Immune Globulin Sales by Country (2024-2029) & (K Units)
Table 107. CSL Behring Company Information
Table 108. CSL Behring Description and Major Businesses
Table 109. CSL Behring Rabies Immune Globulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 110. CSL Behring Rabies Immune Globulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. CSL Behring Recent Developments
Table 112. Grifols Company Information
Table 113. Grifols Description and Major Businesses
Table 114. Grifols Rabies Immune Globulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 115. Grifols Rabies Immune Globulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Grifols Recent Developments
Table 117. Sanofi Company Information
Table 118. Sanofi Description and Major Businesses
Table 119. Sanofi Rabies Immune Globulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 120. Sanofi Rabies Immune Globulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Sanofi Recent Developments
Table 122. Sichuan Yuanda Shuyang Company Information
Table 123. Sichuan Yuanda Shuyang Description and Major Businesses
Table 124. Sichuan Yuanda Shuyang Rabies Immune Globulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 125. Sichuan Yuanda Shuyang Rabies Immune Globulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Sichuan Yuanda Shuyang Recent Developments
Table 127. CNBG Company Information
Table 128. CNBG Description and Major Businesses
Table 129. CNBG Rabies Immune Globulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 130. CNBG Rabies Immune Globulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. CNBG Recent Developments
Table 132. Kamada Company Information
Table 133. Kamada Description and Major Businesses
Table 134. Kamada Rabies Immune Globulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 135. Kamada Rabies Immune Globulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Kamada Recent Developments
Table 137. CBPO Company Information
Table 138. CBPO Description and Major Businesses
Table 139. CBPO Rabies Immune Globulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 140. CBPO Rabies Immune Globulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. CBPO Recent Developments
Table 142. Shuanglin Bio Company Information
Table 143. Shuanglin Bio Description and Major Businesses
Table 144. Shuanglin Bio Rabies Immune Globulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 145. Shuanglin Bio Rabies Immune Globulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Shuanglin Bio Recent Developments
Table 147. Weiguang Bio Company Information
Table 148. Weiguang Bio Description and Major Businesses
Table 149. Weiguang Bio Rabies Immune Globulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 150. Weiguang Bio Rabies Immune Globulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Weiguang Bio Recent Developments
Table 152. Shanghai RAAS Company Information
Table 153. Shanghai RAAS Description and Major Businesses
Table 154. Shanghai RAAS Rabies Immune Globulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 155. Shanghai RAAS Rabies Immune Globulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. Shanghai RAAS Recent Developments
Table 157. Bharat Serum Company Information
Table 158. Bharat Serum Description and Major Businesses
Table 159. Bharat Serum Rabies Immune Globulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 160. Bharat Serum Rabies Immune Globulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 161. Bharat Serum Recent Developments
Table 162. VINS Company Information
Table 163. VINS Description and Major Businesses
Table 164. VINS Rabies Immune Globulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 165. VINS Rabies Immune Globulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 166. VINS Recent Developments
Table 167. Key Raw Materials Lists
Table 168. Raw Materials Key Suppliers Lists
Table 169. Rabies Immune Globulin Distributors List
Table 170. Rabies Immune Globulin Customers List
Table 171. Rabies Immune Globulin Market Trends
Table 172. Rabies Immune Globulin Market Drivers
Table 173. Rabies Immune Globulin Market Challenges
Table 174. Rabies Immune Globulin Market Restraints
Table 175. Research Programs/Design for This Report
Table 176. Key Data Information from Secondary Sources
Table 177. Key Data Information from Primary Sources
List of Figures
Figure 1. Rabies Immune Globulin Product Picture
Figure 2. Global Rabies Immune Globulin Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Rabies Immune Globulin Market Share by Type in 2022 & 2029
Figure 4. ERIG Product Picture
Figure 5. HRIG Product Picture
Figure 6. Global Rabies Immune Globulin Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Rabies Immune Globulin Market Share by Application in 2022 & 2029
Figure 8. Category II Exposure
Figure 9. Category III Exposure
Figure 10. Rabies Immune Globulin Report Years Considered
Figure 11. Global Rabies Immune Globulin Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Rabies Immune Globulin Revenue 2018-2029 (US$ Million)
Figure 13. Global Rabies Immune Globulin Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 14. Global Rabies Immune Globulin Revenue Market Share by Region (2018-2029)
Figure 15. Global Rabies Immune Globulin Sales 2018-2029 ((K Units)
Figure 16. Global Rabies Immune Globulin Sales Market Share by Region (2018-2029)
Figure 17. US & Canada Rabies Immune Globulin Sales YoY (2018-2029) & (K Units)
Figure 18. US & Canada Rabies Immune Globulin Revenue YoY (2018-2029) & (US$ Million)
Figure 19. Europe Rabies Immune Globulin Sales YoY (2018-2029) & (K Units)
Figure 20. Europe Rabies Immune Globulin Revenue YoY (2018-2029) & (US$ Million)
Figure 21. China Rabies Immune Globulin Sales YoY (2018-2029) & (K Units)
Figure 22. China Rabies Immune Globulin Revenue YoY (2018-2029) & (US$ Million)
Figure 23. Asia (excluding China) Rabies Immune Globulin Sales YoY (2018-2029) & (K Units)
Figure 24. Asia (excluding China) Rabies Immune Globulin Revenue YoY (2018-2029) & (US$ Million)
Figure 25. Middle East, Africa and Latin America Rabies Immune Globulin Sales YoY (2018-2029) & (K Units)
Figure 26. Middle East, Africa and Latin America Rabies Immune Globulin Revenue YoY (2018-2029) & (US$ Million)
Figure 27. The Rabies Immune Globulin Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 28. The Top 5 and 10 Largest Manufacturers of Rabies Immune Globulin in the World: Market Share by Rabies Immune Globulin Revenue in 2022
Figure 29. Global Rabies Immune Globulin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 30. Global Rabies Immune Globulin Sales Market Share by Type (2018-2029)
Figure 31. Global Rabies Immune Globulin Revenue Market Share by Type (2018-2029)
Figure 32. Global Rabies Immune Globulin Sales Market Share by Application (2018-2029)
Figure 33. Global Rabies Immune Globulin Revenue Market Share by Application (2018-2029)
Figure 34. US & Canada Rabies Immune Globulin Sales Market Share by Type (2018-2029)
Figure 35. US & Canada Rabies Immune Globulin Revenue Market Share by Type (2018-2029)
Figure 36. US & Canada Rabies Immune Globulin Sales Market Share by Application (2018-2029)
Figure 37. US & Canada Rabies Immune Globulin Revenue Market Share by Application (2018-2029)
Figure 38. US & Canada Rabies Immune Globulin Revenue Share by Country (2018-2029)
Figure 39. US & Canada Rabies Immune Globulin Sales Share by Country (2018-2029)
Figure 40. U.S. Rabies Immune Globulin Revenue (2018-2029) & (US$ Million)
Figure 41. Canada Rabies Immune Globulin Revenue (2018-2029) & (US$ Million)
Figure 42. Europe Rabies Immune Globulin Sales Market Share by Type (2018-2029)
Figure 43. Europe Rabies Immune Globulin Revenue Market Share by Type (2018-2029)
Figure 44. Europe Rabies Immune Globulin Sales Market Share by Application (2018-2029)
Figure 45. Europe Rabies Immune Globulin Revenue Market Share by Application (2018-2029)
Figure 46. Europe Rabies Immune Globulin Revenue Share by Country (2018-2029)
Figure 47. Europe Rabies Immune Globulin Sales Share by Country (2018-2029)
Figure 48. Germany Rabies Immune Globulin Revenue (2018-2029) & (US$ Million)
Figure 49. France Rabies Immune Globulin Revenue (2018-2029) & (US$ Million)
Figure 50. U.K. Rabies Immune Globulin Revenue (2018-2029) & (US$ Million)
Figure 51. Italy Rabies Immune Globulin Revenue (2018-2029) & (US$ Million)
Figure 52. Russia Rabies Immune Globulin Revenue (2018-2029) & (US$ Million)
Figure 53. China Rabies Immune Globulin Sales Market Share by Type (2018-2029)
Figure 54. China Rabies Immune Globulin Revenue Market Share by Type (2018-2029)
Figure 55. China Rabies Immune Globulin Sales Market Share by Application (2018-2029)
Figure 56. China Rabies Immune Globulin Revenue Market Share by Application (2018-2029)
Figure 57. Asia Rabies Immune Globulin Sales Market Share by Type (2018-2029)
Figure 58. Asia Rabies Immune Globulin Revenue Market Share by Type (2018-2029)
Figure 59. Asia Rabies Immune Globulin Sales Market Share by Application (2018-2029)
Figure 60. Asia Rabies Immune Globulin Revenue Market Share by Application (2018-2029)
Figure 61. Asia Rabies Immune Globulin Revenue Share by Region (2018-2029)
Figure 62. Asia Rabies Immune Globulin Sales Share by Region (2018-2029)
Figure 63. Japan Rabies Immune Globulin Revenue (2018-2029) & (US$ Million)
Figure 64. South Korea Rabies Immune Globulin Revenue (2018-2029) & (US$ Million)
Figure 65. China Taiwan Rabies Immune Globulin Revenue (2018-2029) & (US$ Million)
Figure 66. Southeast Asia Rabies Immune Globulin Revenue (2018-2029) & (US$ Million)
Figure 67. India Rabies Immune Globulin Revenue (2018-2029) & (US$ Million)
Figure 68. Middle East, Africa and Latin America Rabies Immune Globulin Sales Market Share by Type (2018-2029)
Figure 69. Middle East, Africa and Latin America Rabies Immune Globulin Revenue Market Share by Type (2018-2029)
Figure 70. Middle East, Africa and Latin America Rabies Immune Globulin Sales Market Share by Application (2018-2029)
Figure 71. Middle East, Africa and Latin America Rabies Immune Globulin Revenue Market Share by Application (2018-2029)
Figure 72. Middle East, Africa and Latin America Rabies Immune Globulin Revenue Share by Country (2018-2029)
Figure 73. Middle East, Africa and Latin America Rabies Immune Globulin Sales Share by Country (2018-2029)
Figure 74. Brazil Rabies Immune Globulin Revenue (2018-2029) & (US$ Million)
Figure 75. Mexico Rabies Immune Globulin Revenue (2018-2029) & (US$ Million)
Figure 76. Turkey Rabies Immune Globulin Revenue (2018-2029) & (US$ Million)
Figure 77. Israel Rabies Immune Globulin Revenue (2018-2029) & (US$ Million)
Figure 78. GCC Countries Rabies Immune Globulin Revenue (2018-2029) & (US$ Million)
Figure 79. Rabies Immune Globulin Value Chain
Figure 80. Rabies Immune Globulin Production Process
Figure 81. Channels of Distribution
Figure 82. Distributors Profiles
Figure 83. Bottom-up and Top-down Approaches for This Report
Figure 84. Data Triangulation
Figure 85. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries